HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

4- (2- (4- (4- ((1- (4- (6- methoxyquinolin- 8- ylamino)pentylamino)- 4- methyl- 1- oxopentan- 2- yl)carbamoyl)phenoxy)benzamido)- 3- methylpentanamido)- 3- hydroxy- 6- methylheptanoic acid butylamide

inhibits both plasmepsins I and II; structure in first source

Also Known As:

ylgucpdmethoxyq cpd

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - Aminoquinolines: 29
        4-(2-(4-(4-((1-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-4-methyl-1-oxopentan-2-yl)carbamoyl)phenoxy)benzamido)-3-methylpentanamido)-3-hydroxy-6-methylheptanoic acid butylamide
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Branched-Chain Amino Acids: 2289
    - Leucine: 6718
      - 4-(2-(4-(4-((1-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-4-methyl-1-oxopentan-2-yl)carbamoyl)phenoxy)benzamido)-3-methylpentanamido)-3-hydroxy-6-methylheptanoic acid butylamide
  - Essential Amino Acids: 1152
    - Leucine: 6718
      - 4-(2-(4-(4-((1-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-4-methyl-1-oxopentan-2-yl)carbamoyl)phenoxy)benzamido)-3-methylpentanamido)-3-hydroxy-6-methylheptanoic acid butylamide